| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom;
Children’s Hospital and
Institute of Pathology, University of Leipzig, Leipzig, Germany;
Department of Immunology, University of Washington, Seattle, WA 98195; and
¶ Zymogenetics, Seattle, WA 98102
CD4+CD25+ regulatory T cells can prevent and resolve intestinal inflammation in the murine T cell transfer model of colitis. Using Foxp3 as a marker of regulatory T cell activity, we now provide a comprehensive analysis of the in vivo distribution of Foxp3+CD4+CD25+ cells in wild-type mice, and during cure of experimental colitis. In both cases, Foxp3+CD4+CD25+ cells were found to accumulate in the colon and secondary lymphoid organs. Importantly, Foxp3+ cells were present at increased density in colon samples from patients with ulcerative colitis or Crohn’s disease, suggesting similarities in the behavior of murine and human regulatory cells under inflammatory conditions. Cure of murine colitis was dependent on the presence of IL-10, and IL-10-producing CD4+CD25+ T cells were enriched within the colon during cure of colitis and also under steady state conditions. Our data indicate that although CD4+CD25+ T cells expressing Foxp3 are present within both lymphoid organs and the colon, subsets of IL-10-producing CD4+CD25+ T cells are present mainly within the intestinal lamina propria suggesting compartmentalization of the regulatory T cell response at effector sites.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the Wellcome Trust (to F.P. and C.T.), the Medical Research Council (to J.C.), Deutsche Forschungsgemeinschaft Grant HU 128-2 (to H.H.U.), the University of Leipzig (to H.H.U., F1-49), the Swiss National Fund (to C.M.), training grants from the National Institutes of Health and the Cancer Research Institute, and the Spanish Ministerio de Educacion y Ciencia (to A.I.).
2 H.H.U. and J.C. contributed equally.
3 Address correspondence and reprint requests to Dr. Fiona Powrie, Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, U.K. E-mail address: fiona.powrie{at}pathology.ox.ac.uk
4 Abbreviations used in this paper: TR, regulatory T cell; IBD, inflammatory bowel disease; MLN, mesenteric lymph node; LP, lamina propria; CD, Crohn’s disease; UC, ulcerative colitis; POD, peroxidase; MHC-II, MHC class II; DAPI, 4',6'-diamidino-2-phenylindole.
This article has been cited by other articles:
|
|
 |
|
  C. E. von Allmen, N. Schmitz, M. Bauer, H. J. Hinton, M. O. Kurrer, R. B. Buser, M. Gwerder, S. Muntwiler, T. Sparwasser, R. R. Beerli, et al. Secretory phospholipase A2-IID is an effector molecule of CD4+CD25+ regulatory T cells PNAS, July 14, 2009; 106(28): 11673 - 11678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gounaris, N. R. Blatner, K. Dennis, F. Magnusson, M. F. Gurish, T. B. Strom, P. Beckhove, F. Gounari, and K. Khazaie T-Regulatory Cells Shift from a Protective Anti-Inflammatory to a Cancer-Promoting Proinflammatory Phenotype in Polyposis Cancer Res., July 1, 2009; 69(13): 5490 - 5497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. Collison, M. R. Pillai, V. Chaturvedi, and D. A. A. Vignali Regulatory T Cell Suppression Is Potentiated by Target T Cells in a Cell Contact, IL-35- and IL-10-Dependent Manner J. Immunol., May 15, 2009; 182(10): 6121 - 6128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Hutton, T. Gargett, T. J. Sadlon, S. Bresatz, C. Y. Brown, H. Zola, M. F. Shannon, R. J. D'Andrea, and S. C. Barry Development of CD4+CD25+FoxP3+ regulatory T cells from cord blood hematopoietic progenitor cells J. Leukoc. Biol., March 1, 2009; 85(3): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Maynard, R. D. Hatton, W. S. Helms, J. R. Oliver, C. B. Stephensen, and C. T. Weaver Contrasting roles for all-trans retinoic acid in TGF-{beta}-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells J. Exp. Med., February 16, 2009; 206(2): 343 - 357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Ostanin, J. Bao, I. Koboziev, L. Gray, S. A. Robinson-Jackson, M. Kosloski-Davidson, V. H. Price, and M. B. Grisham T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G135 - G146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-l. Yu, Y.-m. Cheng, B.-s. Shi, F.-x. Qian, F.-b. Wang, X.-n. Liu, H.-y. Yang, Q.-n. Xu, T.-k. Qi, L.-j. Zha, et al. Measles Virus Infection in Adults Induces Production of IL-10 and Is Associated with Increased CD4+CD25+ Regulatory T Cells J. Immunol., November 15, 2008; 181(10): 7356 - 7366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. McBee, P. Z. Zheng, A. B. Rogers, J. G. Fox, and D. B. Schauer Modulation of Acute Diarrheal Illness by Persistent Bacterial Infection Infect. Immun., November 1, 2008; 76(11): 4851 - 4858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Weigmann, H. A. Lehr, G. Yancopoulos, D. Valenzuela, A. Murphy, S. Stevens, J. Schmidt, P. R. Galle, S. Rose-John, and M. F. Neurath The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis J. Exp. Med., September 1, 2008; 205(9): 2099 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Reardon, A. Wang, and D. M. McKay Transient Local Depletion of Foxp3+ Regulatory T Cells during Recovery from Colitis via Fas/Fas Ligand-Induced Death J. Immunol., June 15, 2008; 180(12): 8316 - 8326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Horino, M. Fujimoto, F. Terabe, S. Serada, T. Takahashi, Y. Soma, K. Tanaka, T. Chinen, A. Yoshimura, S. Nomura, et al. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice Int. Immunol., June 1, 2008; 20(6): 753 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Winstead, J. M. Fraser, and A. Khoruts Regulatory CD4+CD25+Foxp3+ T Cells Selectively Inhibit the Spontaneous Form of Lymphopenia-Induced Proliferation of Naive T Cells J. Immunol., June 1, 2008; 180(11): 7305 - 7317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wakkach, S. Augier, J.-P. Breittmayer, C. Blin-Wakkach, and G. F. Carle Characterization of IL-10-Secreting T Cells Derived from Regulatory CD4+CD25+ Cells by the TIRC7 Surface Marker J. Immunol., May 1, 2008; 180(9): 6054 - 6063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. T. Lau, S. Biester, R. J. Cornall, and J. V. Forrester Lipopolysaccharide-Activated IL-10-Secreting Dendritic Cells Suppress Experimental Autoimmune Uveoretinitis by MHCII-Dependent Activation of CD62L-Expressing Regulatory T Cells J. Immunol., March 15, 2008; 180(6): 3889 - 3899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ho, C. C. Kurtz, M. Naganuma, P. B. Ernst, F. Cominelli, and J. Rivera-Nieves A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis J. Immunol., February 15, 2008; 180(4): 2573 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-G. Chai, D. Coe, D. Chen, E. Simpson, J. Dyson, and D. Scott In Vitro Expansion Improves In Vivo Regulation by CD4+CD25+ Regulatory T Cells J. Immunol., January 15, 2008; 180(2): 858 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Noguchi, D. Wakita, M. Tajima, S. Ashino, Y. Iwakura, Y. Zhang, K. Chamoto, H. Kitamura, and T. Nishimura Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a Th17-independent manner Int. Immunol., December 1, 2007; 19(12): 1431 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nagase, K. M. Jones, C. F. Anderson, and N. Noben-Trauth Despite Increased CD4+Foxp3+ Cells within the Infection Site, BALB/c IL-4 Receptor-Deficient Mice Reveal CD4+Foxp3-Negative T Cells as a Source of IL-10 in Leishmania major Susceptibility J. Immunol., August 15, 2007; 179(4): 2435 - 2444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sakaguchi and F. Powrie Emerging Challenges in Regulatory T Cell Function and Biology Science, August 3, 2007; 317(5838): 627 - 629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Sather, P. Treuting, N. Perdue, M. Miazgowicz, J. D. Fontenot, A. Y. Rudensky, and D. J. Campbell Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease J. Exp. Med., June 11, 2007; 204(6): 1335 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Xu, A. Kitani, I. Fuss, and W. Strober Cutting Edge: Regulatory T Cells Induce CD4+CD25-Foxp3- T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-beta J. Immunol., June 1, 2007; 178(11): 6725 - 6729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nadkarni, C. Mauri, and M. R. Ehrenstein Anti-TNF-{alpha} therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-{beta} J. Exp. Med., January 22, 2007; 204(1): 33 - 39. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
